ondansetron has been researched along with Helicobacter Infections in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engelmann, BE | 1 |
| Bindslev, N | 1 |
| Poulsen, SS | 1 |
| Larsen, R | 1 |
| Hansen, MB | 1 |
1 other study available for ondansetron and Helicobacter Infections
| Article | Year |
|---|---|
Functional characterization of serotonin receptor subtypes in human duodenal secretion.
Topics: Adult; Aged; Bumetanide; Dioxanes; Duodenum; Female; Helicobacter Infections; Helicobacter pylori; H | 2006 |